Searched for
PHASE III TRIALS
Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...- ET Prime Special Series: Multibagger or IBC - Part 59: Japan taught it. Tata bought it. Now EVs will test this auto ancillaryThis is a story about a company that is simultaneously an asset and an anomaly. An asset because it builds a tangible, necessary product, g...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...
- Marco Rubio — The bridge between the Trump–Modi economic doctrineUS Secretary of State Marco Rubio visits India to forge a new economic alliance. This partnership, driven by leaders like President Trump a...
- Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...
- India tests 'Divyastra': How the new multiple-entry nuke missile will boost India's capability to reach any city in China or PakistanIndia successfully flight-tested an advanced Agni-5 missile with MIRV technology, capable of striking multiple targets simultaneously. This...
- ET Prime Special Series: Multibagger or IBC - Part 57: Forging firm that supplies Tata, M&M, JCB. Nobody talks about it enoughFor over four decades, one company has been making crankshafts quietly and precisely, supplying customers from Tata Motors to Liebherr to M...
- Biocon arm denies bribery charges, says cos follows code of conductThe guidelines provide a framework for waiver of phase III clinical trials in India based on a commitment to undertake a phase IV trial, th...
- Aurobindo Pharma, MSN Labs seek DGCI nod for Phase-III trials of Merck's molnupiravirIn a meeting held on October 4, both the companies said that they “they want to discontinue phase III trial in moderate Covid-19 patients a...
- Sanofi, GSK launch Phase III trial for their COVID-19 shotPending positive phase III outcome, the vaccine could be approved in the fourth quarter 2021 after having initially been targeted for the f...
- Biological E gets nod for Phase III trial of its COVID-19 vaccine candidateIts candidate includes an antigen developed by the Texas Childrens Hospital Center for Vaccine Development and in- licensed from BCM Ventur...
- Zydus Cadila to release final vaccine data"The phase III trials for the vaccine are underway and it has been tested on 30,000 healthy adult volunteers in India,” the executive said....
- 1,000 volunteers from Kolkata needed for COVID-19 vaccine - Covaxin - trial at NICEDThe list of 1,000 volunteers will be finalised by the first week of December when the phase III trial is likely to begin.
- Biological E to start phase-III trials by January, license vaccine by summerDisclosing this in Hyderabad on Monday, managing director Mahima Datla said the company is currently evaluating four different formulations...
- Bharat Bio seeks nod for phase-3 trials of indigenous Covid vaccine CovaxinThe company has already approached the states for initiating phase III trials this month. As reported by ET earlier, the company has writte...
- Twenty-six scientists question early-stage trial results of Russia's Sputnik-V vaccine
- Glenmark gets DCGI nod for phase III trials of diarrhoea drugGlenmark Pharmaceuticals today said it has received approval from Drug Controller General of India (DCGI) to conduct phase III trials for C...
- Glenmark Pharma: Miles to go before new drug makes a markGlenmark’s partners — US-based Napo Pharmaceuticals and Salix Pharmaceuticals — have announced completion of phase-III trials for the drug ...
Load More
